Literature DB >> 3297623

The role of arachidonic acid metabolites in cardiovascular homeostasis. Biochemical, histological and clinical cardiovascular effects of non-steroidal anti-inflammatory drugs and their interactions with cardiovascular drugs.

D S Goodman.   

Abstract

Derivatives of arachidonic acid may be involved in atherosclerosis and its clinical complications. There is much interest in pharmacologically manipulating the arachidonic acid cascade as a means of preventing cardiovascular disease. The development of atherosclerosis has been intensively studied and the consequences of cardiovascular or cerebrovascular vessel occlusion are too familiar. Many factors are probably involved, but the role of plasma lipoproteins and the interactions between various constituents of blood and blood vessel walls have received particular attention. The risk of cardiovascular disease associated with high plasma concentrations of the low density lipoproteins and the possible protective effects of high density lipoproteins have been well documented. Much is now known about lipoprotein biochemistry, and the importance of controlling the quantity and quality of dietary lipids has been demonstrated in epidemiological studies. In studies of patients with transient ischaemic attacks, aspirin reduced the risk of stroke and death in males, although these benefits were not as convincingly demonstrated in women. The majority of patients were given aspirin 1300 mg daily, but the optimum dosage was not properly evaluated. Administering aspirin in combination with another antiplatelet drug did not appear to offer any therapeutic advantage in these patients. Aspirin showed a positive, but non-significant trend towards reduced numbers of cardiac events, non-fatal infarcts and total mortality in patients who had experienced at least one myocardial infarction. In contrast, statistically significant beneficial effects were recorded when patients with unstable angina were administered aspirin. The risks of myocardial infarction or coronary death were reduced by 51% in 2 large studies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297623     DOI: 10.2165/00003495-198700331-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  27 in total

Review 1.  Platelet-derived growth factor.

Authors:  C H Heldin; A Wasteson; B Westermark
Journal:  Mol Cell Endocrinol       Date:  1985-03       Impact factor: 4.102

2.  Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits.

Authors:  R J Gryglewski; A Dembińska-Kièć; A Zmuda; T Gryglewska
Journal:  Atherosclerosis       Date:  1978-12       Impact factor: 5.162

Review 3.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

Review 4.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

Review 5.  The pathogenesis of atherosclerosis (first of two parts).

Authors:  R Ross; J A Glomset
Journal:  N Engl J Med       Date:  1976-08-12       Impact factor: 91.245

6.  Lowering blood cholesterol to prevent heart disease. NIH Consensus Development Conference statement.

Authors: 
Journal:  Arteriosclerosis       Date:  1985 Jul-Aug

7.  Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.

Authors:  G Sigurdsson; A Nicoll; B Lewis
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

8.  A randomized trial of aspirin and sulfinpyrazone in threatened stroke.

Authors: 
Journal:  N Engl J Med       Date:  1978-07-13       Impact factor: 91.245

9.  Sulfinpyrazone in the prevention of sudden death after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1980-01-31       Impact factor: 91.245

Review 10.  Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.

Authors:  V Fuster; J H Chesebro
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

View more
  1 in total

1.  Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.

Authors:  Anna Floegel; Tilman Kühn; Disorn Sookthai; Theron Johnson; Cornelia Prehn; Ulrike Rolle-Kampczyk; Wolfgang Otto; Cornelia Weikert; Thomas Illig; Martin von Bergen; Jerzy Adamski; Heiner Boeing; Rudolf Kaaks; Tobias Pischon
Journal:  Eur J Epidemiol       Date:  2017-11-27       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.